Published in Medicine (Baltimore) on January 01, 2016
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology (2010) 14.07
Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med (2011) 8.62
A comparison of goodness-of-fit tests for the logistic regression model. Stat Med (1997) 8.51
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
Guidelines for healthy weight. N Engl J Med (1999) 7.03
Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol (2013) 6.82
The burden of selected digestive diseases in the United States. Gastroenterology (2002) 6.79
Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med (2006) 3.84
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34
Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA (2002) 3.11
American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology (2008) 2.79
Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med (2012) 2.47
Prediction of Barrett's esophagus among men. Am J Gastroenterol (2013) 2.22
Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol (2004) 2.09
Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology (2010) 2.00
Rationale for redefining obesity in Asians. Ann Acad Med Singapore (2009) 1.86
The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther (2007) 1.85
Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets. Stat Med (2012) 1.78
Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.56
Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA (2013) 1.54
Assessing predictive accuracy: how to compare Brier scores. J Clin Epidemiol (1991) 1.52
Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.50
Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study. Am J Gastroenterol (2013) 1.48
Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther (2007) 1.39
Racial and geographic issues in gastroesophageal reflux disease. Am J Gastroenterol (2008) 1.28
The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Gastroenterology (2008) 1.25
The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut (2008) 1.18
Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma. Arch Intern Med (2004) 1.09
A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol (2013) 1.07
Clinical consequences of silent gastroesophageal reflux disease. Curr Gastroenterol Rep (2006) 1.01
Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol (2011) 0.97
Obesity and weight gain as risk factors for erosive oesophagitis in men. Aliment Pharmacol Ther (2009) 0.95
Prevalence of Barrett's esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study. Dig Dis Sci (2009) 0.95
Risk factors for erosive reflux esophagitis: a case-control study. Am J Gastroenterol (2001) 0.94
Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa. Gastroenterology (2013) 0.94
Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Cancer Causes Control (2008) 0.93
Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan. J Gastroenterol (2012) 0.87
From GERD to Barrett's esophagus: is the pattern in Asia mirroring that in the West? J Gastroenterol Hepatol (2011) 0.87
Tobacco smoking cessation and improved gastroesophageal reflux: a prospective population-based cohort study: the HUNT study. Am J Gastroenterol (2013) 0.85
Risk factors on the development of new-onset gastroesophageal reflux symptoms. A population-based prospective cohort study: the HUNT study. Am J Gastroenterol (2015) 0.85
Large waist circumference is a risk factor for reflux esophagitis in Japanese males. Digestion (2010) 0.84
Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus. Best Pract Res Clin Gastroenterol (2014) 0.84
Metabolic syndrome and the risk of Barrett's oesophagus in white males. Aliment Pharmacol Ther (2015) 0.82
Barrett esophagus in Asia: same disease with different pattern. Clin Endosc (2014) 0.81
The role of endoscopy in the management of GERD. Gastrointest Endosc (2015) 0.81
Risk factors for Barrett's esophagus. Curr Opin Gastroenterol (2014) 0.78
Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc (2009) 4.76
Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol (2008) 4.44
Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol (2010) 3.29
Should preoperative chest CT be recommended to all colon cancer patients? Ann Surg (2014) 2.65
β-nicotinamide adenine dinucleotide is an enteric inhibitory neurotransmitter in human and nonhuman primate colons. Gastroenterology (2010) 2.64
Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem (2007) 2.29
Sex-specific characteristics of anthropometry in patients with obstructive sleep apnea: neck circumference and waist-hip ratio. Ann Otol Rhinol Laryngol (2014) 2.04
Coexistence between carotid artery stenosis and colorectal adenomatous polyps in middle-aged men. Digestion (2009) 2.02
Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol (2010) 1.75
Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients. J Gastroenterol Hepatol (2009) 1.71
Asian consensus report on functional dyspepsia. J Gastroenterol Hepatol (2012) 1.66
Is all ineffective esophageal motility the same? A clinical and high-frequency intraluminal US study. Gastrointest Endosc (2008) 1.61
EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointest Endosc (2007) 1.59
The uses of the smartphone for doctors: an empirical study from samsung medical center. Healthc Inform Res (2011) 1.59
A feasibility study on the expanded indication for endoscopic submucosal dissection of early gastric cancer. Surg Endosc (2010) 1.56
Gender-related differences in visceral perception in health and irritable bowel syndrome. J Gastroenterol Hepatol (2006) 1.53
Pathological bolus exposure plays a significant role in eliciting non-cardiac chest pain. J Gastroenterol Hepatol (2010) 1.53
Efficacy and safety of endoscopic treatment for nonampullary sporadic duodenal adenomas. Dig Dis Sci (2013) 1.53
Dysregulation of adipose glutathione peroxidase 3 in obesity contributes to local and systemic oxidative stress. Mol Endocrinol (2008) 1.51
Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann Surg Oncol (2011) 1.50
Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev (2007) 1.50
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea]. Korean J Gastroenterol (2009) 1.48
Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol (2006) 1.43
Comparison of malignant potential between serrated adenomas and traditional adenomas. J Gastroenterol Hepatol (2007) 1.42
Metabolic syndrome is an independent risk factor for synchronous colorectal neoplasm in patients with gastric neoplasm. J Gastroenterol Hepatol (2012) 1.41
Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg (2005) 1.39
[Predictive factors of response to medical therapy in Crohn's disease patients with intestinal obstruction]. Korean J Gastroenterol (2013) 1.39
[C-reactive protein level and colorectal adenoma]. Korean J Gastroenterol (2008) 1.39
Incidence and predictive factors of irritable bowel syndrome after acute diverticulitis in Korea. Int J Colorectal Dis (2014) 1.39
[Microsatellite instability in gastric B-cell lymphoma]. Korean J Gastroenterol (2006) 1.39
Efficacy and tolerability of split-dose magnesium citrate: low-volume (2 liters) polyethylene glycol vs. single- or split-dose polyethylene glycol bowel preparation for morning colonoscopy. Am J Gastroenterol (2010) 1.32
Long-term outcome of early gastric cancer after endoscopic submucosal dissection: expanded indication is comparable to absolute indication. Dig Liver Dis (2013) 1.28
Analysis of pacemaker activity in the human stomach. J Physiol (2011) 1.28
Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area. J Gastroenterol Hepatol (2006) 1.24
Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointest Endosc (2004) 1.23
Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer (2014) 1.23
Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. J Biol Chem (2010) 1.18
Clinical diagnosis of primary epiploic appendagitis: differentiation from acute diverticulitis. J Clin Gastroenterol (2002) 1.17
Risk factors and prognosis of pulmonary complications after endoscopic submucosal dissection for gastric neoplasia. Dig Dis Sci (2012) 1.16
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition]. Korean J Gastroenterol (2013) 1.15
Endoscopic mucosal resection of early gastric cancer: Experiences in Korea. World J Gastroenterol (2007) 1.13
Prevalence and risk factors of Barrett's esophagus in Korea. J Gastroenterol Hepatol (2007) 1.13
Glomus tumor of the stomach: a clinicopathologic analysis of 10 cases and review of the literature. Gut Liver (2012) 1.12
Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci (2008) 1.11
Effects of DA-9701, a novel prokinetic agent, on gastric accommodation in conscious dogs. J Gastroenterol Hepatol (2012) 1.09
Asian consensus report on functional dyspepsia. J Neurogastroenterol Motil (2012) 1.09
Bronchogenic cyst of the stomach masquerading as benign stromal tumor. Pathol Int (2005) 1.08
Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Am J Gastroenterol (2011) 1.07
Double balloon endoscopy in small intestinal Crohn's disease and other inflammatory diseases such as cryptogenic multifocal ulcerous stenosing enteritis (CMUSE). Gastrointest Endosc (2007) 1.07
Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism (2008) 1.07
Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. J Hepatol (2013) 1.07